About Dr. Rupinder Sekhon

• Dr. Rupinder Sekhon is a nationally acclaimed Gynaecological Oncologist with over 45 years of distinguished medical experience, specializing in the surgical management of gynecological cancers.
• She currently leads a state-of-the-art department offering advanced diagnostic and treatment modalities, including colposcopy, laparoscopy, hysteroscopy, open surgeries, and robotic-assisted procedures.
• Dr. Sekhon holds a special clinical interest in ovarian cancer, complex cytoreductive surgeries, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC), particularly for recurrent ovarian cancer cases.
• Her journey began at the Government. Medical College, Amritsar, where she earned her MBBS and DGO, followed by an MD in Obstetrics & Gynaecology from the prestigious Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh.
• She further honed her surgical expertise through a Diploma in Advanced Hysteroscopy and Laparoscopy from Germany and became a Certified Robotic Console Surgeon in the USA in 2011 — making her one of the earliest specialists in India to adopt robotic-assisted surgery in gynecologic oncology.
• Before entering the civilian healthcare sector, Dr. Sekhon served the Indian Air Force for more than 16 years as a Classified Specialist in Obstetrics & Gynaecology, providing critical care and advanced surgical treatment to defense personnel and their families.
• Dr. Sekhon later held key teaching and surgical positions at Rajiv Gandhi University of Medical Sciences, Bangalore, and the Army Hospital (Research & Referral), New Delhi, where she trained future generations of gynecologic oncologists.
• Her professional achievements include being the first surgeon in North India to perform Peritonectomy and HIPEC for ovarian cancer, initiating Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Hyperthermic Intrathoracic Chemotherapy (HITHOC) for advanced gynecological malignancies, and contributing to global research through collaborations with MD Anderson Cancer Centre, USA, and Queensland Cancer Centre, Australia on the landmark LACC Trial (Open vs. Robotic/Laparoscopic Radical Hysterectomy).
• A prolific academic contributor, Dr. Sekhon has been involved in several significant research projects, including pilot studies on Photodynamic Therapy (PDT) for early cervical pre-cancer and Human Papillomavirus (HPV) genotype distribution in cervical cancer in India.
• She is frequently invited as a speaker at international conferences, including Memorial Sloan Kettering Cancer Center, USA, and serves as an Advisory Board Member for HPV vaccination programs with pharmaceutical leaders like MSD and GSK.
• Her leadership in the field is further demonstrated by her memberships in prestigious organizations, including AOGIN (India), AGOI, AOGD, FOGSI, ISOPARB, IAGES, and ISCCP, where she has also served in executive roles.
• Throughout her career, Dr. Sekhon has received numerous accolades, including the Commendation Award on Republic Day by the Commander-in-Chief of the Indian Air Force for Professional Excellence and the Best Gynaecologic Oncologist in Delhi Award (2012) presented by Times Research Media. Her dedication to advancing gynecologic oncology has made her a trusted name among patients and a role model among peers.